Hansoh Pharmaceutical Group Co Ltd - Depreciation and Amortization Expense
Hansoh Pharmaceutical Group Co Ltd's Fiscal Year is From January To December - All Figures are in HKD, Millions.
The item "Depreciation-and-Amortization-Expense" stands at 50.39 Million Hong Kong Dollars for the trailing twelve months (TTM) period ending 03/31/2020, the lowest value since 12/31/2018.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -50.91 percent compared to the value the year prior.
The 1 year change in percent is -50.91.
The 3 year change in percent is 179.84.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 03/31/2020, is +190.31%.
The Serie's change in percent from it's maximum value, on 06/30/2019, to it's latest available value, on 03/31/2020, is -65.02%.
Depreciation and Amortization Expense for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Depreciation and Amortization Expense | 905,699,262,464.00 |
 | Johnson & Johnson - Depreciation and Amortization Expense | 486,508,953,600.00 |
 | AbbVie Inc - Depreciation and Amortization Expense | 399,570,305,024.00 |
 | Roche Holding AG - Depreciation and Amortization Expense | 317,433,206,677.55 |
 | AstraZeneca PLC - Depreciation and Amortization Expense | 280,205,508,085.11 |